Pramine and Armodafinil drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Pramine (imipramine hydrochloride) and Armodafinil (armodafinil). Common drug interactions include fatigue among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Pramine and Armodafinil. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Pramine?
Pramine has active ingredients of imipramine hydrochloride. eHealthMe is studying from 7,461 Pramine users. Check the latest studies of Pramine.
What is Armodafinil?
Armodafinil has active ingredients of armodafinil. It is often used in narcolepsy. eHealthMe is studying from 4,136 Armodafinil users. Check the latest studies of Armodafinil.
19 people who take Pramine and Armodafinil together, and have interactions are studied.

What are the common drug interactions of Pramine and Armodafinil, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Vomiting
- Weight decreased
- Asthenia (weakness)
- Fall
- Gait disturbance
- Hallucination (an experience involving the perception of something not present)
- Hallucination, auditory (perceiving sounds without auditory stimulus)
- Idiopathic intracranial hypertension (elevated cerebrospinal fluid pressure of unknown cause)
- Irritable bowel syndrome
male:
- Chronic kidney disease
- Renal impairment (severely reduced kidney function)
- Gait disturbance
- Gastric disorder (disease of stomach)
- Initial insomnia (feeling of inadequate or poor-quality sleep)
- Insomnia (sleeplessness)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Nasal disorder (diseases of nose)
- Periorbital disorder (gum inflammation to serious disease that results in major damage to the soft tissue and bone that support the teeth)
- Renal tubular necrosis (death of kidney tubules)
What are the common drug interactions of Pramine and Armodafinil, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Aggression
- Dizziness
- Enuresis (repeated inability to control urination)
- Incoherent (talking in a confused and unclear way)
- Nasopharyngitis (inflammation of the nasopharynx)
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
- Psychotic disorder
- Vomiting
20-29:
n/a
30-39:
- Idiopathic intracranial hypertension (elevated cerebrospinal fluid pressure of unknown cause)
40-49:
- Chronic kidney disease
- Renal impairment (severely reduced kidney function)
- Fatigue (feeling of tiredness)
- Irritable bowel syndrome
- Renal failure (kidney dysfunction)
- Abdominal discomfort
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Anxiety
- Apnoea (suspension of external breathing)
- Asthenia (weakness)
50-59:
- Abnormal sleep-related event
- Aortic dilatation
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Periorbital disorder (gum inflammation to serious disease that results in major damage to the soft tissue and bone that support the teeth)
- Somnambulism (sleep walking)
- Weight decreased
- Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
- Decreased appetite
- Enuresis (repeated inability to control urination)
- Feeling drunk
60+:
n/a
What are the existing conditions these people have? *
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 47.37%
- Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 3 people, 15.79%
- Pain: 3 people, 15.79%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 15.79%
- Cardiac Disorder: 3 people, 15.79%
- Inflammation: 3 people, 15.79%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.26%
- Bladder Disorder: 1 person, 5.26%
- Blood Pressure Abnormal: 1 person, 5.26%
- Diabetes: 1 person, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Pramine and Armodafinil?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Pramine (7,461 reports)
- Armodafinil (4,136 reports)
Browse all drug interactions of Pramine and Armodafinil:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pramine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Armodafinil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pramine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Armodafinil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on imipramine hydrochloride and armodafinil (the active ingredients of Pramine and Armodafinil, respectively), and Pramine and Armodafinil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Sulfamethoxazole cause Seronegative Arthritis? - 6 seconds ago
- Drug interactions of Midodrine Hydrochloride and Multihance - 10 seconds ago
- Could Felodipine cause Type 1 Diabetes? - 13 seconds ago
- Could Jakafi cause Blood Sodium Decreased? - 14 seconds ago
- Could Rhinocort cause Dizziness? - 20 seconds ago
- Could Xeljanz cause Drug Hypersensitivity? - 23 seconds ago
- Could Gammagard cause Nasal Congestion? - 23 seconds ago
- Abdominal Discomfort and Ulcer Haemorrhage - 38 seconds ago
- Drug interactions of Tamoxifen Citrate and Levothroid - 44 seconds ago
- Drug interactions of Gemcitabine Hydrochloride and Wellbutrin - 49 seconds ago